References
- Kobashi Y, Mouri K, Obase Y, et al. Serological assay by use of glycopeptidolipid core antigen for Mycobacterium avium complex. Scand J Infect Dis. 2013;45:241–249.
- Jeong BH, Kim SY, Jeon K, et al. Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen. J Clin Microbiol. 2013;51:2747–2749.
- Emori M, Kajiki A, Ikedo Y, et al. 15 cases of pulmonary Mycobacterium scrofulaceum infection. Kekkaku. 2007;82:173–178.
- Sanders JW, Walsh AD, Snider RL, et al. Disseminated Mycobacterium scrofulaceum infection: a potentially treatable complication of AIDS. Clin Infect Dis. 1995;20:549–556.
- Kitada S, Kobayashi K, Ichiyama S, et al. Serodiagnosis of Mycobacterium avium complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med. 2008;177:793–797.
- Numata T, Araya J, Yoshii Y, et al. Clinical efficacy of anti-glycopeptidolipid core IgA test for diagnosing Mycobacterium avium complex infection in lung. Respirology. 2015;20:1277–1281.
- Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29–63.
- Chaterjee D, Khoo KH. The surface glycopeptidolipids of mycobacteria: structures and biological properties. Cell Mol Life Sci. 2001;58:2018–2042.
- Koh WJ, Kwon OJ, Jcon K, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341–348.
- Griffith DE, Askamit T, Brown-Elliot BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.